Brunetti-Pierri, N., Grove, N. C., Zuo, Y., Edwards, R., Palmer, D., Cerullo, V., . . . Ng, P. (2009). Bioengineered Factor IX Molecules with Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. Mary Ann Liebert, Inc.

Brunetti-Pierri, Nicola, Nathan C. Grove, Yu Zuo, Rachel Edwards, Donna Palmer, Vincenzo Cerullo, Jun Teruya, و Philip Ng. Bioengineered Factor IX Molecules With Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. Mary Ann Liebert, Inc, 2009.

Brunetti-Pierri, Nicola, et al. Bioengineered Factor IX Molecules With Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. Mary Ann Liebert, Inc, 2009.